HEALing Communities Study

NCT04111939 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 67

Last updated 2025-05-29

Study results available
· View outcomes & findings →

Summary

This study will test the impact of implementing the Communities That Helping to End Addiction Long-term (HEAL) intervention on opioid overdose deaths within 67 highly affected communities with the goal of reducing opioid overdose deaths by 40%.

Conditions

  • Opioid Use Disorder (OUD)

Interventions

OTHER

Communities That HEAL

The Communities That HEAL (CTH) intervention is a community-engaged intervention designed to increase the adoption of an integrated set of evidence-based practices delivered across healthcare, behavioral health, justice, and other community-based settings. It includes 3 components: community engagement to assist key stakeholders in applying evidence-based practices to addressing their opioid crisis, a menu of evidence-based practices for communities to select and implement, and a communications campaign to build demand for evidence-based practices to address overdose and opioid use disorder.

OTHER

Wait-list control

Communities in the wait-list control condition will continue usual care during the first 30 months of the trial. At month 31, Wave 2 communities will begin receiving the CTH intervention.

Sponsors & Collaborators

  • Boston Medical Center

    collaborator OTHER
  • Columbia University

    collaborator OTHER
  • Ohio State University

    collaborator OTHER
  • University of Kentucky

    collaborator OTHER
  • National Institute on Drug Abuse (NIDA)

    collaborator NIH
  • Substance Abuse and Mental Health Services Administration (SAMHSA)

    collaborator FED
  • RTI International

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-23
Primary Completion
2023-12-31
Completion
2025-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04111939 on ClinicalTrials.gov